New Feature Coming Soon, Stay Tuned!
Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Crescent Biopharma, Inc., an oncology company, develops therapies for cancer patients. Its pipeline includes a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates to treat solid tumors. The company is headquartered in Waltham, Massachusetts.
NASDAQ
0.10Â ( 0.93%)
Relative Strenght
100
Volume Buzz
-96%
Earning Acce
No
Dist 52w H.
82%